Insider · CIK 0001209726
J Kevin Buchi
director
Files at AMRX (Amneal Pharmaceuticals, Inc.), BNTC (Benitec Biopharma Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | AMRX Amneal Pharmaceuticals, Inc. | GGift Class A Common Stock | -20,445 | $0.00 | $0 | 75,077 | 21 d ago |
| Sep 11, 2026 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +20,445 | $14.45 | $295k | 95,522 | 28 d ago |
| Sep 11, 2026 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Stock Optionderivative | -20,445 | $0.00 | $0 | 0 | 28 d ago |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +40,258 | - | - | 40,258 | May 8, 2025 |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -40,258 | $0.00 | $0 | 0 | May 8, 2025 |
| May 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +34,819 | $0.00 | $0 | 34,819 | May 8, 2025 |
| Mar 12, 2025 | BNTC Benitec Biopharma Inc. | GGift Common Stock | -103,626 | $0.00 | $0 | 284 | Mar 13, 2025 |
| Mar 12, 2025 | BNTC Benitec Biopharma Inc. | GGift Common Stockindirect: By Trust | +103,626 | $0.00 | $0 | 103,626 | Mar 13, 2025 |
| Mar 10, 2025 | AMRX Amneal Pharmaceuticals, Inc. | GGift Class A Common Stock | -262,072 | $0.00 | $0 | 0 | Mar 12, 2025 |
| Feb 27, 2025 | BNTC Benitec Biopharma Inc. | MOption exercise Common Stock | +51,813 | $3.86 | $200k | 103,910 | Mar 3, 2025 |
| Feb 27, 2025 | BNTC Benitec Biopharma Inc. | MOption exercise Common Warrants (right to buy)derivative | -51,813 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Dec 9, 2024 | BNTC Benitec Biopharma Inc. | AGrant or award Options (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.